APP and Alzheimer disease: In the study of Alzheimer’s disease, it was discovered that although APP itself is a target of miRNA regulation, amyloid β protein can downregulate miRNAs, including miR-181c and miR-9, both of which inhibit the expression of TGFBI (32).